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Study design: This study was a prospective monocentric study to assess the safety and effectiveness of percutaneous
embolization with coils of postcatheterization femoral pseudoaneurysm (PCFP).
Patients and methods: Seventeen PCFPs of 32-mm mean diameter in 16 patients were embolized while anticoagulant or
antiplatelet therapy was maintained. Ultrasound scan–guided compression repair failed at least one time in 13 cases and
was contraindicated in the four remaining cases. With ultrasound-Doppler scan guidance, the PCFPs were percutaneously
punctured with a 16-gauge intravenous catheter. An angiogram was performed through the catheter to ensure its location
within the sac. Stainless steel spring coils with synthetic fibers were introduced within the PCFP with fluoroscopic
control. Successful thrombosis was checked with ultrasound-Doppler scan and was repeated at days 1, 30, and 180 when
possible.
Results: All PCFPs of 32-mm mean diameter were successfully treated with two to nine coils. After embolization, gentle
additional compression was necessary for complete occlusion, with a mean duration of 6.3 minutes (range, 0 to 15
minutes), except in one case with treatment with abciximab in which it was 45 minutes. All procedures were uneventful
and painless. The mean follow-up period was 9.5 months (range, 1 to 21 months). Two recurrences (11.7%) were
observed, and one was successfully treated with a second embolization.
Conclusion: Percutaneous embolization with coils appears to be a safe and effective method for treatment of PCFP. It may
be performed in patients undergoing anticoagulant or antiplatelet therapy and must be attempted when ultrasound
scan–guided compression repair has failed or is contraindicated. (J Vasc Surg 2002;36:127-31.)
Femoral artery pseudoaneurysms are common compli-
cations after diagnostic (0.2% to 0.5%)1 or therapeutic (up
to 9%) catheterization.2,3 Postcatheterization femoral
pseudoaneurysms (PCFPs) are most commonly associated
with the use of larger catheter size, continued anticoagula-
tion therapy or administration of antiplatelet therapy, and
catheterization of diseased arteries, particularly in an elderly
population.2,4,5 During the past two decades, surgical
treatment has been the recommended approach for preven-
tion of the risk of rupture, compression neuropathy, limb
ischemia, distal embolization, and skin necrosis. This pro-
cedure is fast and can be performed with local anesthesia.
However, the incidence rate of postoperative complications
can be estimated as high as 20%, with a 2% to 3% mortality
rate.1,6 Because of wound complications, the hospital stay
is prolonged (average, 3 days),1 increasing the cost sig-
nificantly. Furthermore, anticoagulation or antiplatelet
therapies have to be stopped to avoid postoperative local
hemorrhage compromising a proper wound healing.
Since its introduction in 1991, ultrasound scan–guided
compression repair (UGCR) has become the first line treat-
ment for PCFP.7 Although success rates can reach 90%, the
significant disadvantages of UGCR include patient discom-
fort, long procedure duration, and lower immediate-term
and long-term success rates in patients undergoing antico-
agulation therapy.8 As an alternative, treatment of PCFP
with direct bovine thrombin injection with sonographic
guidance has been proposed. This procedure lacks the
discomfort of UGCR and, despite the small number of
reported cases, appears to have a success rate greater than
93%.9-14 The Food and Drug Administration has recently
discouraged the use of bovine thrombin, except for topical
use, after receiving four reports of improper administration
(three fatal and one serious but nonfatal) through MED-
WATCH.15 Although none of these cases concerned treat-
ment of PCFP, we believe sufficient concern mandates the
investigation of an alternative approach for PCFP treat-
ment.
Recently, isolated cases of PCFP have been treated
successfully with direct percutaneous coil emboliza-
tion.16-18 We therefore conducted a prospective study to
evaluate the treatment of PCFP with percutaneous punc-
ture and coil embolization in selected patients undergoing
continuous anticoagulant or antiplatelet therapy in whom
UGCR was either contraindicated or failed.
PATIENTS AND METHODS
This prospective study was conducted between No-
vember 1997 and November 1999. During that period, 16
patients (six women and 10 men; mean age, 68 years;
range, 37 to 79 years) underwent treatment for 17 PCFPs
in our institution. Patient characteristics are detailed in the
Table (online only). This was a successive series of patients.
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During the period of the study, four patients were excluded
and needed prompt surgery: two patients because of rup-
tured PCFP, one patient because of an infected PCFP,
and the last patient because of a severe allergy to contrast
media. The applicability of the embolization treatment
during the period of the study was then 17/21 (81%).
According to the American Society of Anesthesiology phys-
ical status classification, all patients had at least classification
3. According to the American College of Cardiology, 12
patients were at major risk of increased perioperative car-
diovascular risk, three were at intermediary risk, and one
was at minor risk.19 All patients were at least undergoing
antiplatelet or anticoagulant therapy (Table, online only).
One patient was undergoing treatment with abciximab
(Reopro), an inhibitor of the platelet glycoprotein IIb/IIIa
receptor, and aspirin. Patients had 17 PCFPs occurring
after diagnostic coronary angiography in nine cases, after
coronary angioplasty in six cases, with coronary stenting in
five cases, after renal angioplasty in one case, and after
retrieval procedure with a snare in one case. One patient
had two PCFPs on both femoral arteries after two coronary
angiographies performed at a 6-week interval. The catheter
sheath size range was 6F (n  11), 8F (n  5), and 10F
(n  1).
After informed consent was obtained, all patients un-
derwent exploration with duplex ultrasound scan and color
flow imaging (Fig 1, A). The PCFP maximal diameter size
ranged from 1.7 to 5.0 cm, with a mean diameter of 3.2 cm.
UGCR failed one time in seven cases and two times in three
cases, with compression times ranging between 25 and 45
minutes. In three cases, UGCR in combination with Femo-
stop (3 hours, 12 hours, and 12 hours) failed. In four cases,
UGCR was contraindicated because the patients had dis-
comfort and pain.
The procedures were performed with local anesthesia
(10 mL of Xylocaine 1% [Astra Zeneca, France]). With
ultrasound-Doppler scan guidance, a 16-gauge intravenous
catheter was percutaneously positioned within the PCFP.
An angiogram was performed through the catheter to
ensure its location and to detect associated arteriovenous
fistula (AVF). With fluoroscopic guidance, stainless steel
spring coils with synthetic fibers (IMWCE-35, Cook, Bjae-
verskov, Denmark) of 4 to 15 cm in length and 10 mm in
diameter once deployed were delivered through the cathe-
ter within the PCFP. No migration within the native artery
was observed while the coils were delivered. The catheter
was withdrawn in case of contrast media stagnation within
the pseudoaneurysm sac and the absence of visualization of
femoral arterial tree after repeated control angiogram
(Fig 2). If necessary, manual compression was performed
after coil embolization until the final control with ultra-
sound-Doppler scan confirmed the total thrombosis of the
PCFP. Distal pulses were checked, and patients were kept
on bed rest for 24 hours. Patients underwent clinical re-
view, and an ultrasound-Doppler scan was performed at
day 1 and at 1, 3, 6, and 12 months.
RESULTS
Immediate results (Table I, online only). The punc-
ture of the PCFP was successful in all of the cases. The
angiograms confirmed the precise location of the intrave-
nous catheter within the sac of the pseudoaneurysm.
PCFPs were located on the superficial femoral artery (n 
8), on the common femoral artery (n  6), and on the
femoral bifurcation (n  3). Three additional AVFs were
observed. All procedures were uneventful. An average of
3.8 coils (two to nine) was delivered without pain or other
difficulty. No rupture of the PCFP or migration of coils was
observed. After coil embolization, no compression was
necessary in three cases. For the patient undergoing treat-
Fig 1. Duplex ultrasound scan of pseudoaneurysm located at
femoral bifurcation before (A) and after (B) coil embolization.
Coils appear as hyperechogenic images within lumen of PCFP
(arrows).
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ment with abciximab and aspirin, the time of compression
necessary for complete occlusion was 45 minutes. In the 16
remaining cases, the mean duration of a gentle compression
necessary for complete occlusion was 6.3minutes (range,
0 to 15 minutes). Ultrasound-Doppler scan confirmed the
thrombosis of all PCFPs immediately and after 24 hours
(Fig 1, B). No local or general complications were observed.
All patients were discharged from our care at 24 hours.
Late results (Table I, online only). Two recurrences
were observed during the follow-up period. In a first pa-
tient, hospitalized in another center, a new ultrasound-
Doppler scan showed a partial recanalization of the PCFP 1
week after successful embolization. The patient underwent
successful operation without any new attempt of coil em-
bolization. (The ultrasound-Doppler scan report shows a
possible residual flow in the neck, but we nevertheless
consider this was a recurrence because an additional treat-
ment was performed). The second patient was seen 1
month after the first embolization with a new 15-mm
diameter PCFP located next to the first treated PCFP,
which remained occluded. The new PCFP was successfully
embolized with two coils of 4-mm diameter and 3-cm
length. This patient died of terminal cardiac insufficiency
11 months later while waiting for heart transplantation
without recurrence. All the 15 remaining patients (includ-
ing the patient with recurrence treated with new efficient
embolization) were available for clinical follow-up (mean
period, 9.5 months; range, 1 to 21 months) and sono-
graphic follow-up (mean period, 5 months; range, 1 day to
17.5 months).
In the remaining 16 PCFPs, clinical follow-up was
satisfactory without recurrence. Ultrasound-Doppler scan
confirmed the thrombosis in at least 13 PCFPs at 1 month.
In two patients, only clinical follow-up was available and
confirmed thrombosis at 16 and 18 months. Seven patients
were available for follow-up after 6 months with ultra-
sound-Doppler scan showing no recurrence. Twelve pa-
tients were available for clinical follow-up after 6 months.
Three patients have had another ipsilateral femoral cath-
eterism without difficulty.
DISCUSSION
Simple observation is not recommended in patients
with PCFPs larger than 2 cm in diameter.20 Consequently,
surgical treatment has been advocated as the reference
treatment. Although the surgical repair is definitive, the
incidence rate of complications is increased and scar forma-
tion may make future groin access difficult.1 Moreover, it
prolongs the hospital stay and increases the cost signifi-
cantly. In the same way, patients with PCFPs needing
continued anticoagulation and antiplatelet therapy are cur-
rently not considered good candidates for UGCR.8 This
method consists of the compression of the neck of the
pseudoaneurysm with the ultrasound scan transducer to
interrupt aneurysmal flow inducing the thrombosis of the
PCFP. UGCR can be performed safely and is inexpensive,
yet it can be time consuming. The mean duration of com-
pression necessary for successful thrombosis is commonly
high (28 to 104 minutes),8,21-24 and multiple attempts are
sometimes necessary. In addition, the patients may have
pain, discomfort, and bradycardia. The failure rates of
UGCR range from 7% to 70%, especially when patients are
undergoing anticoagulation or antiplatelet therapy.8,25-27
In this report, we present a less invasive alternative for
operative treatment of PCFP without modification of anti-
coagulant or antiplatelet regimens. In our series, apparition
of PCFP seems to be related to the size (superior than 6F)
of the sheath. In addition, the location of the initial punc-
ture, too low in the superficial femoral artery or at the
bifurcation, far from the femoral head may favor the emer-
gence of PCFP because of inefficient compression maneu-
ver.
The direct puncture of PCFP is a 100% efficient
method compared with the contralateral approach pro-
posed by some authors, which is more complex and pre-
sents risks of development of contralateral PCFP or any
other local complication.17,28 Moreover, catheterization of
the neck is time-consuming and sometimes unsuccessful,
making those techniques anecdotal. We choose to control
our procedure with ultrasound-Doppler scan and fluoros-
copy to avoid downstream migration of coil and to confirm
thrombosis of PCFP.
The success rate of coil embolization of 88.3% is correct
but not the greatest for a problem like PCFP. However,
one case of recurrence occurred in bilobed pseudoaneu-
rysm, which is more prone to recurrence and frequently
necessitates a second treatment.14 Concerning the other
patient who underwent reoperation in an other center, the
so-called recurrence was in fact a persistent flow in the neck
that should not have necessitated reintervention. However,
to be totally honest, it was difficult to withdraw the patient
from the study.
Fig 2. Angiogram performed through 16-gauge catheter shows
large, bilobed PCFP located at superficial femoral artery (A). After
embolization with coils, absence of visualization of arterial tree and
stagnation of iodine contrast within lumen of PCFP indicates
complete thrombosis (B).
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Recently some publications reported highly successful
treatment of PCFP with direct injection of thrombin with
ultrasound-Doppler scan guidance.9-13 Thrombin injec-
tion is a quick method, uses less expensive resources, and
avoids a foreign body. This technique is better than UGCR
and seems to have now a wide acceptance within the
vascular community. However, we think that thrombin
injection is not 100% safe because thrombotic complica-
tions have been reported at least in five cases resulting from
leakage of thrombin into systemic circulation.10,29-32 In
addition, one fatal pulmonary embolism occurred in a case
in which an AVF was associated to the pseudoaneurysm.33
In fact, association of AVF and PCFP is relatively common,
and in our series of 17 PCAPs, AVF was present three times.
According to its promoters, one could avoid that compli-
cation by injecting slowly a lower volume, adapted to
aneurysm size, of highly concentrated thrombin without
filling the neck. Kang et al10 emitted special limits concern-
ing thrombin injection in PCFP with short and wide neck.
In our reported method, morphology of the neck is not a
limit because of the possibility of use of a coil larger than the
neck.
Probably because of its mammalian origin, bovine
thrombin is associated with risk of anaphylactic reaction.
Moreover, bovine thrombin induced antibodies directed
against bovine thrombin and other coagulation factors.34 A
prolonged generalized urticarial reaction has been de-
scribed after percutaneous thrombin injection for treat-
ment of PCFP.35 Similarly, a patient with a PCFP and a
history of exposure to bovine thrombin had a severe ana-
phylactic reaction after thrombin treatment.36 Conse-
quently, injection in patients with previous exposure to
thrombin should be avoided.35 Furthermore, bovine
thrombin is not allowed for use in France and in other
European countries exposed to bovine spongiform enceph-
alopathy, in addition to the Food and Drug Administration
recommendations.
In our series, all patients were undergoing anticoagu-
lation or antiplatelet therapy. These treatment could not
have been removed because of coronary risk. It seems
intuitive that conservation of these treatments decreases
cardiac mortality or morbidity in those cases of patients at
high risk, particularly for PCFP occurring in early follow-up
of coronary angioplasty or stenting (six cases in our series)
or when cardiac arrhythmia is associated (three cases). No
local bleeding complications were observed.
Theoretic complications of coil embolization include
local infection as the result of hematoma, implantation of
synthetic material, and percutaneous access. Infection of
embolization material had been described37 but remains
rare and was not observed in our series. However, we think
that coil embolization is contraindicated in infected groin.
In this preliminary study, we can conclude that percu-
taneous coil embolization is a safe, quick, and well-toler-
ated treatment of PCFP and authorizes preprocedure and
postprocedure conservation of anticoagulant or antiplatelet
therapy. Unlike bovine thrombin, coil embolization avoids
adverse events as immune or anaphylactic response and is
authorized in all countries. Our study suggests that in case
of PCFP, percutaneous coil embolization should be at-
tempted when ultrasound scan–guided compression has
failed or is contraindicated.
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Appendix, online only. Calculating process in
mathematical model
At the end of the first tiptoe cycle, the pressure P1 can
be expressed as follows:
P1  P0  x P0  I,
where P0 is the resting pressure, x is the pressure reduction
fraction per each step, and I is the constant pressure in-
crease per step. Similarly, at the end of nth tiptoe cycle, the
following equation can be derived:
Pn  Pn  1  x Pn  1  I, which can be transformed to:
Pn  (1  x) Pn  1  I.
When a is substituted for (1 x), the previous equation
becomes:
Pn  a Pn  1  I (1)
With equation 1, the pressure at each tiptoe cycle can
be expressed as follows:
P1  a P0  I
P2  a P1  I  a2 P0  a I  I
P3  a P2  I  a3 P0  a2 I  a I  I
Pn  an P0  an1 I  an2 I , I
 an P0  (an1  an2  1) I (2)
Pn  an P0  (1an) I/(1  a)
At the asymptotic behavior when the pressure reduc-
tion per step is equal to I, n becomes infinite and an is
approximated to zero because a 1. Therefore, equation 2
can become:
P  I/(1  a) (3)
Then, substituting I/(1  a) in equation 2 with P
from equation 3,
Pn  an P0  (1  an) P (4)
Pn  P  an (P0  P)
Taking logarithms of equation 4, the following equa-
tion can be obtained:
log10 (Pn  P)  n log10 a  log10 (P0  P) (5)
1
